elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q61894668-8B9D9333-D477-4786-8A36-662390E245EA
Q61894668-8B9D9333-D477-4786-8A36-662390E245EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q61894668-8B9D9333-D477-4786-8A36-662390E245EA
A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome
P6099
Q61894668-8B9D9333-D477-4786-8A36-662390E245EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q61894668-8B9D9333-D477-4786-8A36-662390E245EA
rank
NormalRank
type
BestRank
Statement
P6099
phase II clinical trial